A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma

NCT00925314 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Stage IIIB Skin Melanoma
Stage IIIC Skin Melanoma

Interventions

BIOLOGICAL: CB-10-01 (Transgenic Lymphocyte Immunization)

Sponsor

Cosmo Bioscience